Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Curve founder: KelpDAO attack triggers Aave bad debts, exposing non-isolated lending risks

Curve founder: KelpDAO attack triggers Aave bad debts, exposing non-isolated lending risks

BlockBeatsBlockBeats2026/04/19 02:37
Show original

BlockBeats News, on April 19, Curve founder Michael Egorov stated: "I hope Aave can resolve this issue. Kelp DAO suffered a loss of about $292 million due to an attack, which led to bad debt on Aave. This is precisely the risk brought by the commonly used 'non-isolated lending' model. This model has good scalability, but higher risk, so risk management is crucial (Aave has historically performed well in this aspect).


One approach is to use a fully isolated model like Curve Finance’s market, while another is to adopt a hybrid model (complex but feasible). However, the market has not yet fully understood the advantages of these schemes. The hub and spoke model of Aave v4 may be a step toward a semi-isolated and safer direction."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

German factory orders exceed expectations for three consecutive months, signaling a gradual economic recovery

Data released by the German Federal Statistical Office on Thursday showed that factory orders increased by 2.5% month-on-month in July. The figure for June was revised upwards to a 3.7% increase.

智通财经2026/09/04 07:36
German factory orders exceed expectations for three consecutive months, signaling a gradual economic recovery

Roche (RHHBY.US) Vamixibai monoclonal antibody injection's marketing application accepted by CDE for the treatment of uveitic macular edema

According to the official website of the CDE, the marketing application for Roche (RHHBY.US) Vamiki bai monoclonal antibody injection has been accepted.

智通财经2026/09/04 07:31
Roche (RHHBY.US) Vamixibai monoclonal antibody injection's marketing application accepted by CDE for the treatment of uveitic macular edema